RedHill Biopharma Elaborates on Its Announced Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. PNR
2. ONON
3. IAUX
4. KKR
5. DAVA
6. MONC:IM
7. MONRY
8. NYXH
9. THO
10. JG

Go back to RedHill Biopharma Elaborates on Its Announced Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.55 --0 (-0%)
Previous Close $0.55    52 Week High $16.54 
Open $0.55    52 Week Low $8.10 
Day High $0.55    P/E N/A 
Day Low $0.55    EPS $0.00 
Volume 615       

REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.55 --0 (-0%)
Previous Close $0.55    52 Week High $16.54 
Open $0.55    52 Week Low $8.10 
Day High $0.55    P/E N/A 
Day Low $0.55    EPS $0.00 
Volume 615